Share on LinkedInShare on LinkedIn

ARTICLE · 29 MAY 2013

Did a gene patent save Angelina Jolie's life?

This recent news has increased the intensity of the spotlight on the gene patent debate in both the US and Australia.

AustraliaIntellectual Property

The recent news that Angelina Jolie tested positive for the BRCA1 mutation and has consequently undergone a prophylactic double mastectomy to guard against developing breast cancer has increased the intensity of the spotlight on the gene patent debate currently playing out in both the United States Supreme Court in Association for Molecular Pathology v. Myriad Genetics, Inc, and in the Full Federal Court of Australia in Cancer Voices Australia v Myriad Genetics Inc.

In April 2013, the US Supreme Court heard arguments in relation to the patentability of isolated human genes, which are claimed in patents held by Myriad Genetics, Inc. A decision by the Supreme Court is expected in June 2013. Earlier this year, we reported on the landmark decision of the Federal Court that confirmed the patentability of isolated nucleotide sequences (genes) in Australia. This decision is currently under appeal. For more information, refer to the article at the following link.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from